Confluence Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $106M | Sell |
|
|||||
|
2025
Q2 | $108M | Sell |
|
|||||
|
2025
Q1 | $110M | Sell |
|
|||||
|
2024
Q4 | $109M | Sell |
|
|||||
|
2024
Q3 | $99.9M | Sell |
|
|||||
|
2024
Q2 | $82.5M | Sell |
|
|||||
|
2024
Q1 | $91.3M | Sell |
|
|||||
|
2023
Q4 | $103M | Sell |
|
|||||
|
2023
Q3 | $97.1M | Sell |
|
|||||
|
2023
Q2 | $101M | Sell |
|
|||||
|
2023
Q1 | $110M | Sell |
|
|||||
|
2022
Q4 | $116M | Buy |
|
|||||
|
2022
Q3 | $82.7M | Buy |
|
|||||
|
2022
Q2 | $81M | Buy |
|
|||||
|
2022
Q1 | $75.9M | Buy |
|
|||||
|
2021
Q4 | $90M | Buy |
|
|||||
|
2021
Q3 | $85.5M | Buy |
|
|||||
|
2021
Q2 | $83.6M | Buy |
|
|||||
|
2021
Q1 | $77M | Buy |
|
|||||
|
2020
Q4 | $64.5M | Sell |
|
|||||
|
2020
Q3 | $76.3M | Sell |
|
|||||
|
2020
Q2 | $96M | Sell |
|
|||||
|
2020
Q1 | $96.3M | Buy |
|
|||||
|
2019
Q4 | $81.7M | Sell |
|
|||||
|
2019
Q3 | $78.3M | Buy |
|
|||||
|
2019
Q2 | $81.7M | Buy |
|
|||||
|
2019
Q1 | $78M | Buy |
|
|||||
|
2018
Q4 | $72.7M | Sell |
|
|||||
|
2018
Q3 | $92M | Sell |
|
|||||
|
2018
Q2 | $86.2M | Buy |
|
|||||
|
2018
Q1 | $59.3M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $3.65M | Buy |
|
|||||
|
2014
Q2 | $2.68M | Buy |
|